Literature DB >> 33444711

The interaction between brain and liver regulates lipid metabolism in the TBI pathology.

Victoria Palafox-Sánchez1, Zhe Ying1, Luiz Fernando Freire Royes2, Fernando Gomez-Pinilla3.   

Abstract

To shed light on the impact of systemic physiology on the pathology of traumatic brain injury (TBI), we examine the effects of TBI (concussive injury) and dietary fructose on critical aspects of lipid homeostasis in the brain and liver of young-adult rats. Lipids are integral components of brain structure and function, and the liver has a role on the synthesis and metabolism of lipids. Fructose is mainly metabolized in the liver with potential implications for brain function. Lipidomic analysis accompanied by unbiased sparse partial least squares discriminant analysis (sPLS-DA) identified lysophosphatidylcholine (LPC) and cholesterol ester (CE) as the top lipid families impacted by TBI and fructose in the hippocampus, and only LPC (16:0) was associated with hippocampal-dependent memory performance. Fructose and TBI elevated liver pro-inflammatory markers, interleukin-1α (IL-1α), Interferon-γ (IFN-γ) that correlated with hippocampal-dependent memory dysfunction, and monocyte chemoattractant protein-1 (MCP-1) positively correlated with LPC levels in the hippocampus. The effects of fructose were more pronounced in the liver, in agreement with the role of liver on fructose metabolism and suggest that fructose could exacerbate liver inflammation caused by TBI. The overall results indicate that TBI and fructose interact to influence systemic and central inflammation by engaging liver lipids. The impact of TBI and fructose diet on the periphery provides a therapeutic target to counteract the TBI pathogenesis.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Fructose; Liver; Lysophosphatidylcholine; Traumatic brain injury; cPLA2

Mesh:

Year:  2021        PMID: 33444711      PMCID: PMC7889047          DOI: 10.1016/j.bbadis.2021.166078

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  66 in total

1.  Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Authors:  Sang Won Seo; Rebecca F Gottesman; Jeanne M Clark; Ruben Hernaez; Yoosoo Chang; Changsoo Kim; Kyoung Hwa Ha; Eliseo Guallar; Mariana Lazo
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

2.  Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy.

Authors:  Colin P Doherty; Eoin O'Keefe; Eugene Wallace; Teresa Loftus; James Keaney; John Kealy; Marian M Humphries; Michael G Molloy; James F Meaney; Michael Farrell; Matthew Campbell
Journal:  J Neuropathol Exp Neurol       Date:  2016-05-31       Impact factor: 3.685

3.  Group 1B phospholipase A₂ deficiency protects against diet-induced hyperlipidemia in mice.

Authors:  Norris I Hollie; David Y Hui
Journal:  J Lipid Res       Date:  2011-09-09       Impact factor: 5.922

Review 4.  Dietary fructose as a model to explore the influence of peripheral metabolism on brain function and plasticity.

Authors:  Fernando Gomez-Pinilla; Rafael Parcianello Cipolat; Luiz Fernando Freire Royes
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-26       Impact factor: 5.187

5.  Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men.

Authors:  David Faeh; Kaori Minehira; Jean-Marc Schwarz; Raj Periasamy; Raj Periasami; Seongsu Park; Park Seongsu; Luc Tappy
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

6.  High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase.

Authors:  Takuji Ishimoto; Miguel A Lanaspa; Christopher J Rivard; Carlos A Roncal-Jimenez; David J Orlicky; Christina Cicerchi; Rachel H McMahan; Manal F Abdelmalek; Hugo R Rosen; Matthew R Jackman; Paul S MacLean; Christine P Diggle; Aruna Asipu; Shinichiro Inaba; Tomoki Kosugi; Waichi Sato; Shoichi Maruyama; Laura G Sánchez-Lozada; Yuri Y Sautin; James O Hill; David T Bonthron; Richard J Johnson
Journal:  Hepatology       Date:  2013-10-08       Impact factor: 17.425

7.  Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.

Authors:  Keisuke Kakisaka; Yuji Suzuki; Yudai Fujiwara; Akiko Suzuki; Jo Kanazawa; Yasuhiro Takikawa
Journal:  J Gastroenterol Hepatol       Date:  2018-09-23       Impact factor: 4.029

8.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance.

Authors:  Song-Yang Zhang; Yong-Qiang Dong; Pengcheng Wang; Xingzhong Zhang; Yu Yan; Lulu Sun; Bo Liu; Dafang Zhang; Heng Zhang; Huiying Liu; Wei Kong; Gang Hu; Yatrik M Shah; Frank J Gonzalez; Xian Wang; Changtao Jiang
Journal:  EBioMedicine       Date:  2018-04-27       Impact factor: 8.143

10.  Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance.

Authors:  W A Banks; S A Farr; T S Salameh; M L Niehoff; E M Rhea; J E Morley; A J Hanson; K M Hansen; S Craft
Journal:  Int J Obes (Lond)       Date:  2017-10-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.